Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05788848 · ClinicalTrials.gov registry record · Phase 1
Virtual Reality Cognitive Therapy for Alzheimer's Disease
A Phase 1 study of Alzheimer Disease, sponsored by Claritytek.
- Completed
- Registry status
- Phase 1
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT05788848 is a Phase 1 study of Alzheimer Disease that has completed, run by Claritytek. The registered enrollment target is 36 participants, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05788848, a Phase 1 study of Alzheimer Disease, has completed, sponsored by Claritytek.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate the usability, feasibility, and acceptability of VRCT iteratively on 36 AD/ADRD individuals with mild to moderate CI.
Conditions Studied
Interventions
- BEHAVIORAL VRCT
Study Locations (1)
Minnesota
- HealthPartners - Saint Paul
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2023-03-31 |
| Est. Completion | 2024-08-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05788848
The ClinicalTrials.gov registry entry for NCT05788848 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (99% lower). The listed sponsor is Claritytek, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which VRCT is the first listed.
NCT05788848 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT05788848 about?
NCT05788848 is a clinical study titled "Virtual Reality Cognitive Therapy for Alzheimer's Disease". To evaluate the usability, feasibility, and acceptability of VRCT iteratively on 36 AD/ADRD individuals with mild to moderate CI.
What is the current status of trial NCT05788848?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2023-03-31. Estimated completion is 2024-08-31.
What conditions does trial NCT05788848 study?
This clinical trial studies the following conditions: Alzheimer Disease.
What interventions are being tested in trial NCT05788848?
The interventions under investigation include: VRCT (BEHAVIORAL).
Who is sponsoring clinical trial NCT05788848?
This trial is sponsored by Claritytek, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05788848 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease
RECRUITING · Phase 1
-
Study to Evaluate the Relative Bioavailability of a New Formulation of NPT 2042 Soft-Gelatin Capsules Compared to the Original Formulation of NPT 2042
RECRUITING · Phase 1
-
Nicotinic Acid for the Treatment of Alzheimer's Disease
RECRUITING · Phase 1
-
A Phase Ia/Ib, First-in-human (FIH) Study for Safety, Tolerability, Pharmacokinetics (PK), and Clinical Activity Evaluation of ADEL-Y01
RECRUITING · Phase 1
-
Deep Repetitive Transcranial Magnetic Stimulation (rTMS) of the Precuneus for Alzheimer Disease (AD)
RECRUITING · Phase 1
-
Assess Fibrin in Brains With AD/ADRD
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.